These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15465610)

  • 61. Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Rajaei T; Farajifard H; Rafatpanah H; Bustani R; Valizadeh N; Rajaei B; Rezaee SA
    Med Microbiol Immunol; 2017 Jun; 206(3):195-201. PubMed ID: 28378248
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interferon Lambda Family along with HTLV-1 Proviral Load, Tax, and HBZ Implicated in the Pathogenesis of Myelopathy/Tropical Spastic Paraparesis.
    Mozhgani SH; Jahantigh HR; Rafatpanah H; Valizadeh N; Mohammadi A; Basharkhah S; Rezaee SA
    Neurodegener Dis; 2018; 18(2-3):150-155. PubMed ID: 29990995
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection.
    Rocha-Júnior MC; Haddad R; Cilião Alves DC; de Deus Wagatsuma VM; Mendes-Junior CT; Deghaide NH; Takayanagui OM; Covas DT; Donadi EA; Kashima S
    Tissue Antigens; 2012 Aug; 80(2):143-50. PubMed ID: 22587568
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis.
    Lenzi ME; Cuzzi-Maya T; Oliveira AL; Andrada-Serpa MJ; Araújo AQ
    Clin Infect Dis; 2003 Feb; 36(4):507-13. PubMed ID: 12567310
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human T cell lymphotropic virus type I (HTLV-I) p12I is dispensable for HTLV-I transmission and maintenance of infection in vivo.
    Furukawa Y; Usuku K; Izumo S; Osame M
    AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1092-9. PubMed ID: 15585100
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.
    Yasuma K; Matsuzaki T; Yamano Y; Takashima H; Matsuoka M; Saito M
    J Neurovirol; 2016 Aug; 22(4):416-30. PubMed ID: 26635027
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
    Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
    J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.
    Arai M; Kannagi M; Matsuoka M; Sato T; Yamamoto N; Fujii M
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):261-7. PubMed ID: 9491917
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy.
    Cavrois M; Leclercq I; Gout O; Gessain A; Wain-Hobson S; Wattel E
    Oncogene; 1998 Jul; 17(1):77-82. PubMed ID: 9671316
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals.
    Sabouri AH; Saito M; Usuku K; Bajestan SN; Mahmoudi M; Forughipour M; Sabouri Z; Abbaspour Z; Goharjoo ME; Khayami E; Hasani A; Izumo S; Arimura K; Farid R; Osame M
    J Gen Virol; 2005 Mar; 86(Pt 3):773-781. PubMed ID: 15722539
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing.
    Kalume F; Lee SM; Morcos Y; Callaway JC; Levin MC
    J Neurosci Res; 2004 Jul; 77(1):82-9. PubMed ID: 15197740
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Ijichi S; Ijichi N; Osame M
    Nihon Rinsho; 1997 Apr; 55(4):926-33. PubMed ID: 9103896
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vestibular-evoked myogenic potential (VEMP) to evaluate cervical myelopathy in human T-cell lymphotropic virus type I infection.
    Felipe L; Gonçalves DU; Santos MA; Proietti FA; Ribas JG; Carneiro-Proietti AB; Lambertucci JR
    Spine (Phila Pa 1976); 2008 May; 33(11):1180-4. PubMed ID: 18469690
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease.
    Oh U; Yamano Y; Mora CA; Ohayon J; Bagnato F; Butman JA; Dambrosia J; Leist TP; McFarland H; Jacobson S
    Ann Neurol; 2005 Apr; 57(4):526-34. PubMed ID: 15786444
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
    J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
    Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human T-cell lymphotropic virus type I (HTLV-I) confirmed by PCR-Southern blot and sequencing analysis in a woman with tropical spastic paraparesis.
    Perandin F; Cariani A; Bonfanti C; Trainini L; Magoni M; Manca N
    Neurol Sci; 2006 Sep; 27(4):257-60. PubMed ID: 16998729
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lack of tax diversity for tropical spastic paraparesis/human T-cell lymphotropic virus type 1 (HTLV-I) associated myelopathy development in HTLV-I-infected subjects in São Paulo, Brazil.
    Casseb J; Fukumori L; Vergara M; Sanabani S; Marchiori P; Duarte A; Oliveira Ad
    Mem Inst Oswaldo Cruz; 2006 May; 101(3):273-6. PubMed ID: 16862321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro cytoskeleton changes of mouse neurons induced by purified HTLV-1, and PBMC from HAM/TSP patients and HTLV-1 carriers.
    Ramirez E; Cartier L; Flores R
    Arch Virol; 2004 Dec; 149(12):2307-17. PubMed ID: 15338322
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM.
    Cavrois M; Gessain A; Wain-Hobson S; Wattel E
    Oncogene; 1996 Jun; 12(11):2419-23. PubMed ID: 8649783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.